Organon (OGN) Other Accumulated Expenses (2023)

Organon (OGN) recorded quarterly Other Accumulated Expenses of $1.0 million in Q4 2023.

Organon (OGN) Other Accumulated Expenses (2023) Analysis & Trends

Organon's Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $1.0 million for Q4 2023.

In Q4 2023, Other Accumulated Expenses changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2023 stood at $1.0 million (changed N/A YoY), while the FY2023 annual figure was $1.0 million, changed N/A from the prior year.
Other Accumulated Expenses was $1.0 million for Q4 2023 at Organon.
In the past five years, Other Accumulated Expenses ranged from a high of $1.0 million in Q4 2023 to a low of $1.0 million in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,026,132.38 Bn	93,026,127.42 Bn	7.76 Bn
2	Eli Lilly	1,022.62 Bn	1,017.34 Bn	16.22 Bn
3	Johnson & Johnson	570.65 Bn	548.59 Bn	15.96 Bn
4	AbbVie	398.73 Bn	389.38 Bn	10.78 Bn
5	Merck	295.53 Bn	289.88 Bn	12.09 Bn
6	Amgen	186.30 Bn	174.26 Bn	5.87 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn
8	Pfizer	146.09 Bn	133.32 Bn	-1.21 Bn
9	Bristol Myers Squibb	114.98 Bn	104.53 Bn	8.07 Bn
10	Organon	3.49 Bn	2.37 Bn	783.00 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2023	1.00 Mn